Strong Correlation Between Concentrations of Tenofovir (TFV) Emtricitabine (FTC) in Hair and TFV Diphosphate and FTC Triphosphate in Dried Blood Spots in the iPrEx Open Label Extension: Implications for Pre-exposure Prophylaxis Adherence Monitoring

Strong Correlation Between Concentrations of Tenofovir (TFV) Emtricitabine (FTC) in Hair and TFV Diphosphate and FTC Triphosphate in Dried Blood Spots in the iPrEx Open Label Extension: Implications for Pre-exposure Prophylaxis Adherence Monitoring

Item

http://www.wikidata.org/entity/Q36149022

Q36149022

about

Biomarkers and biometric measures of adherence to use of ARV-based vaginal rings Adherence to Pre-Exposure Prophylaxis for HIV Prevention in a Clinical Setting Quantifying Isoniazid Levels in Small Hair Samples: A Novel Method for Assessing Adherence during the Treatment of Latent and Active Tuberculosis Community member perspectives from transgender women and men who have sex with men on pre-exposure prophylaxis as an HIV prevention strategy: implications for implementation.Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice.Cost-Effectiveness of Pre-exposure HIV Prophylaxis During Pregnancy and Breastfeeding in Sub-Saharan Africa.Association of age, baseline kidney function, and medication exposure with declines in creatinine clearance on pre-exposure prophylaxis: an observational cohort study.Attitudes and perceptions towards novel objective measures of ARV-based vaginal ring use: Results from a global stakeholder survey.Differences in Cumulative Exposure and Adherence to Tenofovir in the VOICE, iPrEx OLE, and PrEP Demo Studies as Determined via Hair Concentrations.Hair Levels of PrEP Drugs Measure Adherence and are Associated with Renal Decline Among Men/Transwomen in an Open Label PrEP Study.Comparison of Measures of Adherence to HIV Preexposure Prophylaxis among Adolescent and Young Men Who Have Sex with Men in the United States.Adherence biomarker measurements in older and younger HIV-infected adults receiving tenofovir-based therapy.Isoniazid concentrations in hair and plasma area-under-the-curve exposure among children with tuberculosis.Comparing pharmacologic measures of tenofovir exposure in a U.S. pre-exposure prophylaxis randomized trial.Comparison of tenofovir plasma and tissue exposure using a population pharmacokinetic model and bootstrap: a simulation study from observed data.Development and Validation of an Assay to Analyze Atazanavir in Human Hair Via Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).Adherence Measurements in HIV: New Advancements in Pharmacologic Methods and Real-Time Monitoring.Novel methods to estimate antiretroviral adherence: protocol for a longitudinal study.

P2860

Q26753097-284B1898-7069-4C0A-9435-DFFABAAD3CA4 Q28552015-28132AD1-5C63-4F3E-9678-536A869CA559 Q28552186-89D84A59-8D25-4DA7-845D-36EE9D6CF908 Q36480354-9B4AA8AF-9E18-4F13-85AA-3589A554DDBD Q36710299-C09799CE-C8DF-4FB1-94F0-5FD7CF46ABAC Q37298218-FFAD0545-813C-4A9C-9CA9-00654AA5D20E Q37377643-21E2EE50-25DE-4F15-95C5-8242C23FD519 Q38678847-3022AA72-9A8C-4DC9-A9D6-FAC44BC230D0 Q38851078-CFD3DA8F-A9EA-4A24-9A77-0253523FE342 Q40074158-39276914-CFB2-451C-920F-FFA949F051E6 Q45947819-77E9DE78-5676-4F3B-B1F3-49942B0AD0E2 Q45976122-2F071010-13DD-493E-9B42-018A41E7A734 Q46679475-3C8A05EF-15C9-4872-AEC0-B5153ABE7187 Q47556636-669B6B29-1DFB-44E4-8FB0-13951C07C24C Q47628152-B53A68D7-5F08-4202-A28C-BD7D59E63CEA Q47724822-41B586E2-C84A-4D9E-A637-2E84E7DA3A6E Q49587788-B516860C-B9FE-4C4E-B516-316768D4E17F Q55311524-215F97F1-BC7A-4446-A1CE-F16B2F09B987

P2860

Strong Correlation Between Concentrations of Tenofovir (TFV) Emtricitabine (FTC) in Hair and TFV Diphosphate and FTC Triphosphate in Dried Blood Spots in the iPrEx Open Label Extension: Implications for Pre-exposure Prophylaxis Adherence Monitoring

Item

http://www.wikidata.org/entity/Q36149022

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Strong Correlation Between Con ...... ophylaxis Adherence Monitoring

@ast

Strong Correlation Between Con ...... ophylaxis Adherence Monitoring

@en

type

Item

label

Strong Correlation Between Con ...... ophylaxis Adherence Monitoring

@ast

Strong Correlation Between Con ...... ophylaxis Adherence Monitoring

@en

prefLabel

Strong Correlation Between Con ...... ophylaxis Adherence Monitoring

@ast

Strong Correlation Between Con ...... ophylaxis Adherence Monitoring

@en

P1476

Strong Correlation Between Con ...... ophylaxis Adherence Monitoring

@en

P2093

Albert Liu

http://www.w3.org/2001/XMLSchema#string

David V Glidden

http://www.w3.org/2001/XMLSchema#string

Howard Horng

http://www.w3.org/2001/XMLSchema#string

Monica Gandhi

http://www.w3.org/2001/XMLSchema#string

Patricia Defechereux

http://www.w3.org/2001/XMLSchema#string

Peter L Anderson

http://www.w3.org/2001/XMLSchema#string

Suwat Chariyalertsak

http://www.w3.org/2001/XMLSchema#string

iPrEx Study Team

http://www.w3.org/2001/XMLSchema#string

P2860

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women

Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial

Strong relationship between oral dose and tenofovir hair levels in a randomized trial: hair as a potential adherence measure for pre-exposure prophylaxis (PrEP)

Preexposure prophylaxis for HIV infection among African women

Tenofovir-based preexposure prophylaxis for HIV infection among African women.

HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention.

Antiretroviral concentrations in small hair samples as a feasible marker of adherence in rural Kenya

Comparing the novel method of assessing PrEP adherence/exposure using hair samples to other pharmacologic and traditional measures

Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure.

P304

1402-1406

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/INFDIS/JIV239

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

212

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-04-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275278732

http://www.w3.org/2001/XMLSchema#string

P698

25895984

http://www.w3.org/2001/XMLSchema#string

P932

4601920

http://www.w3.org/2001/XMLSchema#string

Strong Correlation Between Concentrations of Tenofovir (TFV) Emtricitabine (FTC) in Hair and TFV Diphosphate and FTC Triphosphate in Dried Blood Spots in the iPrEx Open Label Extension: Implications for Pre-exposure Prophylaxis Adherence Monitoring

about

P2860

P2860

Strong Correlation Between Concentrations of Tenofovir (TFV) Emtricitabine (FTC) in Hair and TFV Diphosphate and FTC Triphosphate in Dried Blood Spots in the iPrEx Open Label Extension: Implications for Pre-exposure Prophylaxis Adherence Monitoring

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932